These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16940058)

  • 1. Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years.
    Jullien V; Urien S; Hirt D; Delaugerre C; Rey E; Teglas JP; Vaz P; Rouzioux C; Chaix ML; Macassa E; Firtion G; Pons G; Blanche S; Tréluyer JM
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3548-55. PubMed ID: 16940058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.
    Jullien V; Raïs A; Urien S; Dimet J; Delaugerre C; Bouillon-Pichault M; Rey E; Pons G; Blanche S; Tréluyer JM
    Br J Clin Pharmacol; 2007 Jul; 64(1):105-9. PubMed ID: 17324223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment.
    Bouillon-Pichault M; Jullien V; Azria E; Pannier E; Firtion G; Krivine A; Compagnucci A; Taulera O; Finkielsztejn L; Chhun S; Pons G; Launay O; Treluyer JM
    J Antimicrob Chemother; 2009 Jun; 63(6):1223-32. PubMed ID: 19389715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients.
    Bouillon-Pichault M; Jullien V; Piketty C; Viard JP; Morini JP; Chhun S; Krivine A; Salmon D; Dupin N; Weiss L; Lortholary O; Pons G; Launay O; Treluyer JM
    Antivir Ther; 2009; 14(7):923-9. PubMed ID: 19918096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
    Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
    Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.
    Jullien V; Tréluyer JM; Rey E; Jaffray P; Krivine A; Moachon L; Lillo-Le Louet A; Lescoat A; Dupin N; Salmon D; Pons G; Urien S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3361-6. PubMed ID: 16048948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults.
    van der Leur MR; Burger DM; la Porte CJ; Koopmans PP
    Ther Drug Monit; 2006 Oct; 28(5):650-3. PubMed ID: 17038880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women.
    Hirt D; Treluyer JM; Jullien V; Firtion G; Chappuy H; Rey E; Pons G; Mandelbrot L; Urien S
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2079-86. PubMed ID: 16723569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below.
    Verweel G; Burger DM; Sheehan NL; Bergshoeff AS; Warris A; van der Knaap LC; Driessen G; de Groot R; Hartwig NG
    Antivir Ther; 2007; 12(4):453-8. PubMed ID: 17668553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
    Mirochnick M; Cooper E; Capparelli E; McIntosh K; Lindsey J; Xu J; Jacobus D; Mofenson L; Bonagura VR; Nachman S; Yogev R; Sullivan JL; Spector SA
    Clin Pharmacol Ther; 2001 Jul; 70(1):24-32. PubMed ID: 11452241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of amlodipine in hypertensive children and adolescents.
    Flynn JT; Nahata MC; Mahan JD; Portman RJ;
    J Clin Pharmacol; 2006 Aug; 46(8):905-16. PubMed ID: 16855075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tolerability of once- versus twice-daily lopinavir/ritonavir treatment in HIV-1-infected children.
    la Porte C; van Heeswijk R; Mitchell CD; Zhang G; Parker J; Rongkavilit C
    Antivir Ther; 2009; 14(4):603-6. PubMed ID: 19578247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.
    Jullien V; Tréluyer JM; Chappuy H; Dimet J; Rey E; Dupin N; Salmon D; Pons G; Urien S
    Br J Clin Pharmacol; 2005 Feb; 59(2):183-8. PubMed ID: 15676040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily.
    van der Flier M; Verweel G; van der Knaap LC; van Jaarsveld P; Driessen GJ; van der Lee M; Hartwig NG; Burger DM
    Antivir Ther; 2008; 13(8):1087-90. PubMed ID: 19195335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
    Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
    J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.